nivolumab in lung cancer

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
nivolumab in lung cancer	1.99	0.4	5882	98	24
nivolumab	1.92	0.9	4590	23	9
in	1.72	1	4882	31	2
lung	1.81	0.6	6872	63	4
cancer	1.29	0.6	6311	14	6

Keyword	CPC	PCC	Volume	Score
nivolumab in lung cancer	1.3	0.3	9779	85
nivolumab and pembrolizumab for lung cancer	0.19	0.4	2670	38
nivolumab for small cell lung cancer	0.53	0.7	2898	48
nivolumab and ipilimumab lung cancer	0.07	0.8	7074	59
nivolumab for early stage lung cancer	1.55	0.9	5442	57
small cell lung cancer nivolumab dose	0.61	0.6	2672	43
small cell lung cancer nivolumab nejm	0.13	0.4	1715	1
small cell lung cancer nivolumab results	0.66	0.1	344	28
pembrolizumab for lung cancer	0.18	0.8	1143	75
nivolumab and pembrolizumab combination	1.24	0.9	8419	92
nivolumab and pembrolizumab for melanoma	1.6	0.9	72	35
nivolumab and pembrolizumab for mesothelioma	1.16	0.2	4717	13
nivolumab for lung cancer	1.73	0.7	5624	2
pembrolizumab lung cancer fda	0.95	0.5	3469	58
pembrolizumab chemotherapy lung cancer	1.43	0.8	8852	19
pembrolizumab single agent lung cancer	1.36	0.5	1964	17
nejm pembrolizumab lung cancer	0.91	0.4	5008	81
nivolumab pembrolizumab and atezolizumab	0.82	1	5838	6
pembrolizumab adjuvant lung cancer	0.19	0.5	3306	88
neoadjuvant pembrolizumab lung cancer	0.38	0.2	714	38
pembrolizumab small cell lung cancer	1.81	0.2	5370	93
pembrolizumab metastatic lung cancer	1.23	1	4157	37
pembrolizumab versus nivolumab for melanoma	1.12	0.9	3414	78
pembrolizumab non small cell lung cancer nejm	1.09	0.8	2657	88
pembrolizumab lung cancer fda approval	1.22	0.1	4112	55
lung cancer chemo drug nivolumab	1.84	0.7	8929	90
pembrolizumab compared to nivolumab	1.58	0.1	1700	97
pembrolizumab keynote metastatic lung cancer	1.66	0.5	6114	24
pembrolizumab vs nivolumab mechanism	1.45	0.7	8043	14